By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company China Resources Boya Bio-pharmaceutical Group Co., Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)

SHZ Currency in CNY
¥26.61
-¥0.09
-0.34%
Last Update: 29 Aug 2025, 07:04
¥13.42B
Market Cap
34.61
P/E Ratio (TTM)
1.20%
Forward Dividend Yield
¥25.33 - ¥41.98
52 Week Range

300294.SZ Stock Price Chart

Explore China Resources Boya Bio-pharmaceutical Group Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300294.SZ price movements and trends.

300294.SZ Company Profile

Discover essential business fundamentals and corporate details for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Mar 2012

Employees

1.94K

CEO

Huacheng Liang

Description

China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin sodium injections for various fields, such as medicine, hepatitis, gynecology, and immunomodulation. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Fuzhou, China.

300294.SZ Financial Timeline

Browse a chronological timeline of China Resources Boya Bio-pharmaceutical Group Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 22 Aug 2025

EPS came in at ¥0.24 matching the estimated ¥0.24.

Dividend declared on 28 May 2025

A dividend of ¥0.16 per share was announced, adjusted to ¥0.16. The dividend was paid on 28 May 2025.

Earnings released on 24 Apr 2025

EPS came in at ¥0.28 surpassing the estimated ¥0.27 by +3.70%, while revenue for the quarter reached ¥535.88M , missing expectations by 0.00%.

Earnings released on 18 Mar 2025

EPS came in at -¥0.03 falling short of the estimated ¥0.28 by -110.71%, while revenue for the quarter reached ¥489.80M .

Dividend declared on 25 Oct 2024

A dividend of ¥0.16 per share was announced, adjusted to ¥0.16. The dividend was paid on 25 Oct 2024.

Earnings released on 24 Oct 2024

EPS came in at ¥0.19 falling short of the estimated ¥0.30 by -36.67%, while revenue for the quarter reached ¥349.37M .

Earnings released on 23 Aug 2024

EPS came in at ¥0.33 surpassing the estimated ¥0.26 by +26.92%, while revenue for the quarter reached ¥443.28M .

Dividend declared on 26 Apr 2024

A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 26 Apr 2024.

Earnings released on 23 Apr 2024

EPS came in at ¥0.30 surpassing the estimated ¥0.28 by +7.14%, while revenue for the quarter reached ¥448.45M , missing expectations by -77.12%.

Earnings released on 14 Mar 2024

EPS came in at -¥0.45 , while revenue for the quarter reached ¥457.20M .

Earnings released on 25 Oct 2023

EPS came in at ¥0.27 , while revenue for the quarter reached ¥649.53M .

Earnings released on 21 Aug 2023

EPS came in at ¥0.31 , while revenue for the quarter reached ¥734.94M .

Dividend declared on 28 Apr 2023

A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 28 Apr 2023.

Earnings released on 24 Apr 2023

EPS came in at ¥0.34 , while revenue for the quarter reached ¥805.93M , missing expectations by -55.53%.

Earnings released on 12 Mar 2023

EPS came in at ¥0.03 , while revenue for the quarter reached ¥675.96M .

Earnings released on 24 Oct 2022

EPS came in at ¥0.28 , while revenue for the quarter reached ¥684.03M .

Earnings released on 19 Aug 2022

EPS came in at ¥0.34 , while revenue for the quarter reached ¥744.08M .

Dividend declared on 13 May 2022

A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 13 May 2022.

Earnings released on 22 Apr 2022

EPS came in at ¥0.21 , while revenue for the quarter reached ¥654.64M .

Earnings released on 23 Mar 2022

EPS came in at ¥0.05 falling short of the estimated ¥0.41 by -87.95%, while revenue for the quarter reached ¥639.03M , missing expectations by -36.22%.

Earnings released on 28 Oct 2021

EPS came in at ¥0.29 , while revenue for the quarter reached ¥716.66M .

Earnings released on 27 Aug 2021

EPS came in at ¥0.22 , while revenue for the quarter reached ¥670.72M .

Dividend declared on 26 May 2021

A dividend of ¥0.07 per share was announced, adjusted to ¥0.07. The dividend was paid on 26 May 2021.

Earnings released on 27 Apr 2021

EPS came in at ¥0.24 , while revenue for the quarter reached ¥655.84M .

Earnings released on 31 Mar 2021

EPS came in at ¥0.24 , while revenue for the quarter reached ¥624.12M .

Earnings released on 30 Oct 2020

EPS came in at ¥0.15 , while revenue for the quarter reached ¥660.95M .

300294.SZ Stock Performance

Access detailed 300294.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run